Altium Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-150,000
| Closed | -$2.45M | – | 122 |
|
|
2022
Q3 | $2.45M | Hold |
150,000
| – | – | 0.9% | 43 |
|
|
2022
Q2 | $2.18M | Sell |
150,000
-93,000
| -38% | -$1.35M | 0.87% | 43 |
|
|
2022
Q1 | $4.49M | Buy |
243,000
+18,000
| +8% | +$332K | 1.5% | 23 |
|
|
2021
Q4 | $5.35M | Hold |
225,000
| – | – | 1.47% | 18 |
|
|
2021
Q3 | $5.54M | Buy |
225,000
+36,400
| +19% | +$897K | 1.45% | 22 |
|
|
2021
Q2 | $4.66M | Buy |
188,600
+10,000
| +6% | +$247K | 1.08% | 32 |
|
|
2021
Q1 | $3.9M | Buy |
+178,600
| New | +$3.9M | 1.08% | 33 |
|